Skip to main content
SpringerLink
Log in

Bevacizumab/fluorouracil/folinic acid/irinotecan

Neutropenic sepsis, epistaxis and hypertension: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Comella P, et al. Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF regimen) in patients with metastatic colorectal cancer: The southern Italy cooperative oncology group experience. Clinical Colorectal Cancer 10: 42-47, No. 1, Mar 2011 - Italy

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bevacizumab/fluorouracil/folinic acid/irinotecan. Reactions Weekly 1552, 39 (2015). https://doi.org/10.1007/s40278-015-0835-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-0835-z

Search

Navigation